Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Nektar to receive $135M from Pfizer

NKTR will receive a $135 million one-time payment from PFE to satisfy

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE